A novel method of screening thrombin-inhibiting DNA aptamers using an evolution-mimicking algorithm

被引:82
作者
Ikebukuro, K
Okumura, Y
Sumikura, K
Karube, I
机构
[1] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Tokyo 1848588, Japan
[2] Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan
[3] Natl Grad Inst Policy Studies, Minato Ku, Tokyo 1068677, Japan
[4] Tokyo Univ Technol, Sch Bion, Tokyo 1920982, Japan
基金
日本学术振兴会;
关键词
D O I
10.1093/nar/gni108
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Thrombin-inhibiting DNA aptamers have already been obtained through the systematic evolution of ligands by exponential enrichment (SELEX). However, SELEX is a method that screens DNA aptamers that bind to their target molecules, and it sometimes fails to screen good inhibitors. Therefore, it is necessary to develop a method of screening DNA aptamers based on their inhibitory effects on the target molecules. We developed a novel method of detecting aptamers using an evolution-mimicking algorithm, and we applied it to the search of new aptamers which inhibit thrombin. First, we randomly designed and synthesized ten 15mer oligonucleotides presumed to form G-quartet structures, and then measured their thrombin-inhibiting activities. The aptamers showing high inhibitory activity were selected, and we shuffled and mutated those sequences in silico to generate 10 new sequences of next-generation aptamers. After repeating the cycle five times, we successfully obtained the same aptamers reported previously, and they showed high inhibitory activity. In addition, we added 8mer oligonucleotides to both the 5' and the 3' end of the selected 15mer aptamers, and then repeated the evolution in silico. After two cycles, we were able to obtain aptamers with higher inhibitory activity than that of the 15mer aptamers.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 30 条
[1]   SELECTION OF SINGLE-STRANDED-DNA MOLECULES THAT BIND AND INHIBIT HUMAN THROMBIN [J].
BOCK, LC ;
GRIFFIN, LC ;
LATHAM, JA ;
VERMAAS, EH ;
TOOLE, JJ .
NATURE, 1992, 355 (6360) :564-566
[2]   PILOT-STUDY OF THE EFFICACY OF A THROMBIN INHIBITOR FOR USE DURING CARDIOPULMONARY BYPASS [J].
DEANDA, A ;
COUTRE, SE ;
MOON, MR ;
VIAL, CM ;
GRIFFIN, LC ;
LAW, VS ;
KOMEDA, M ;
LEUNG, LLK ;
MILLER, DC .
ANNALS OF THORACIC SURGERY, 1994, 58 (02) :344-350
[3]   Proximity extension of circular DNA aptamers with real-time protein detection [J].
Di Giusto, DA ;
Wlassoff, WA ;
Gooding, JJ ;
Messerle, BA ;
King, GC .
NUCLEIC ACIDS RESEARCH, 2005, 33 (06) :1-7
[4]   INVITRO SELECTION OF RNA MOLECULES THAT BIND SPECIFIC LIGANDS [J].
ELLINGTON, AD ;
SZOSTAK, JW .
NATURE, 1990, 346 (6287) :818-822
[5]   Aptamer structures from A to zeta [J].
Feigon, J ;
Dieckmann, T ;
Smith, FW .
CHEMISTRY & BIOLOGY, 1996, 3 (08) :611-617
[6]   Aptamers as ligands in affinity probe capillary electrophoresis [J].
German, I ;
Buchanan, DD ;
Kennedy, RT .
ANALYTICAL CHEMISTRY, 1998, 70 (21) :4540-4545
[7]  
GOLDBERG DE, 1989, GENETIC ALGORITHM SE
[8]   INVIVO ANTICOAGULANT PROPERTIES OF A NOVEL NUCLEOTIDE-BASED THROMBIN INHIBITOR AND DEMONSTRATION OF REGIONAL ANTICOAGULATION IN EXTRACORPOREAL CIRCUITS [J].
GRIFFIN, LC ;
TIDMARSH, GF ;
BOCK, LC ;
TOOLE, JJ ;
LEUNG, LLK .
BLOOD, 1993, 81 (12) :3271-3276
[9]   Identification of critical residues on thrombin mediating its interaction with fibrin [J].
Hall, SW ;
Gibbs, CS ;
Leung, LLK .
THROMBOSIS AND HAEMOSTASIS, 2001, 86 (06) :1466-1474
[10]  
Hesselberth J, 2000, J Biotechnol, V74, P15, DOI 10.1016/S1389-0352(99)00005-7